[go: up one dir, main page]

FR3113563B1 - Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids - Google Patents

Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids Download PDF

Info

Publication number
FR3113563B1
FR3113563B1 FR2008960A FR2008960A FR3113563B1 FR 3113563 B1 FR3113563 B1 FR 3113563B1 FR 2008960 A FR2008960 A FR 2008960A FR 2008960 A FR2008960 A FR 2008960A FR 3113563 B1 FR3113563 B1 FR 3113563B1
Authority
FR
France
Prior art keywords
plant
phytocannabinoids
extracted
liquids
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2008960A
Other languages
French (fr)
Other versions
FR3113563A1 (en
Inventor
Soic Gay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cids France
Original Assignee
Cids France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cids France filed Critical Cids France
Priority to FR2008960A priority Critical patent/FR3113563B1/en
Publication of FR3113563A1 publication Critical patent/FR3113563A1/en
Application granted granted Critical
Publication of FR3113563B1 publication Critical patent/FR3113563B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L’invention concerne une méthode d’utilisation des phytocannabinoïdes végétaux provenant de la variété Sativa L., contenant moins de 0,2 % de Tétrahydrocannabinol (THC) et restreint à des composés sans effets psychotropes pour la fabrication de e-liquides. Lesdits phytocannabinoïdes végétaux étant extraits par méthode de distillation. La méthode étant caractérisée par une étape préalable avant le mélange des composants du e-liquide consistant à procéder à une dissolution d’un soluté de phytocannabinoïdes végétaux extrait par méthode de distillation avec le mono propylène glycol végétal.The invention relates to a method for using plant phytocannabinoids from the Sativa L. variety, containing less than 0.2% Tetrahydrocannabinol (THC) and restricted to compounds without psychotropic effects for the manufacture of e-liquids. Said plant phytocannabinoids are extracted by distillation method. The method is characterized by a preliminary step before mixing the components of the e-liquid consisting of dissolving a solute of plant phytocannabinoids extracted by distillation method with plant monopropylene glycol.

FR2008960A 2020-09-03 2020-09-03 Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids Active FR3113563B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2008960A FR3113563B1 (en) 2020-09-03 2020-09-03 Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2008960A FR3113563B1 (en) 2020-09-03 2020-09-03 Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids
FR2008960 2020-09-03

Publications (2)

Publication Number Publication Date
FR3113563A1 FR3113563A1 (en) 2022-03-04
FR3113563B1 true FR3113563B1 (en) 2025-05-02

Family

ID=78828132

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2008960A Active FR3113563B1 (en) 2020-09-03 2020-09-03 Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids

Country Status (1)

Country Link
FR (1) FR3113563B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150181924A1 (en) * 2013-10-31 2015-07-02 Michael R. Llamas Cannabidiol liquid composition for smoking
EP3150264A1 (en) * 2015-09-30 2017-04-05 Bionorica Ethics GmbH Vacuum distillation for enriching cbd
FR3062303B1 (en) * 2017-02-01 2019-11-29 Laboratoires Ceres LIQUID VAPORIZABLE FORMULATION COMPRISING AT LEAST ONE DIOL AND AT LEAST ONE CANNABINOID COMPOUND
US10932497B2 (en) * 2017-03-30 2021-03-02 Markham Biotech Inc. Cannabinoid formulations for aerosol devices and methods thereof
CA2993834C (en) * 2017-04-24 2025-09-23 Oracle Scientific Ltd. Preparation of a solution of cannabinoids for personal vaping

Also Published As

Publication number Publication date
FR3113563A1 (en) 2022-03-04

Similar Documents

Publication Publication Date Title
GB1250236A (en)
FR3113563B1 (en) Use of plant phytocannabinoids extracted by distillation method for the manufacture of e-liquids
BR112019007169A2 (en) production of tert-butyl hydroperoxide solution and process to form products thereof
CN109111337B (en) Separation equipment and method for mixed solvent containing toluene, ethyl acetate, ethanol and the like
US20210403447A1 (en) Process for preparing dioxolane
CN107903223A (en) Solvent recovery separation method containing tetrahydrofuran-methanol system
UY39859A (en) TRAYS WITH VALVES IN EXTRACTION COLUMNS
FR3115036B1 (en) Process for separating molecules from a mixture of fluids comprising at least one fluorinated component
US2349275A (en) Separation of tocopherol from scum with solvents
US2759800A (en) Liquid-liquid contacting device
CA3156074A1 (en) MLL1 INHIBITORS AND ANTICANCER AGENTS
GB709660A (en) Improvements in or relating to method and apparatus for operating a vapor liquid contacting zone
EP0799813A2 (en) Distillation process for the recovery of pure products from crude anthracene
FR3110425B1 (en) METHOD FOR OBTAINING A SANDALWOOD EXTRACT, COMPOSITIONS COMPRISING IT AND COSMETIC USES THEREOF
FR3128706B1 (en) PROCESS FOR LIQUID-LIQUID EXTRACTION OF RARE EARTH ELEMENTS OR ACTINIDES VIA THE COMBINATION OF A HYDROTROPIC CO-SOLVENT AGENT WITH CHELATING OR ANIONIC EXTRACTANTS
US2655468A (en) Recovering solvent from process steam
MA54666A1 (en) Extraction of cannabinoids, flavonoids and terpenes from cannabis
EP3900732A4 (en) COMPOSITION COMPRISING AN EXTRACT OF CHINESE SUMAC AND A FRAXINE AS ACTIVE PRINCIPLES FOR THE IMPROVEMENT OF COGNITIVE ABILITY AND FOR THE PREVENTION OR TREATMENT OF DEMENTIA AND HIDPERACTIVITY DISORDER
EA202191894A1 (en) LIQUID COMPOSITIONS
US2891098A (en) Purification of halohydrins
GB788712A (en) Improvements in or relating to distillation apparatus
MY176002A (en) Process for producing crude palm fruit oil
FR3110572B1 (en) Xanthene derivative, mixtures comprising it, method of manufacture and corresponding uses
Gaile et al. Extraction of toluene and xylenes from the toluene-xylene fraction of the reforming catalyzate with mixtures of triethylene glycol with sulfolane
GB473343A (en) Improvements in the manufacture of hydrogen peroxide

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20220422

PLFP Fee payment

Year of fee payment: 3

ST Notification of lapse

Effective date: 20220505

FC Decision of inpi director general to approve request for restoration

Effective date: 20220531

RN Application for restoration

Effective date: 20220531

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20240506

FC Decision of inpi director general to approve request for restoration

Effective date: 20240530

RN Application for restoration

Effective date: 20240524